mRNA Vaccines & Therapeutics

Delve into process development mRNA therapeutics and saRNA approaches. Including:

• Advancing mRNA Vaccine Technologies To Improve Stability, Efficacy & Delivery
  
• Increasing RNA Based Medicine Safety Profiles via saRNA Preclinical Development
  
• Moving mRNA From The Research Lab To Commercial Manufacturing
  
• Innovating And Producing R&D And GMP mRNA
  
• Route To Clinic – Critical Steps For mRNA Process Optimization

Oligo-based Therapeutics

Explore movement to clinic of ASOs, siRNA and short RNAs. Including:

• RNAi Therapeutics Targeting Tumor Microenvironment 
  
• Organophosphorus Process Strategies In Oligonucleotide Synthesis 
  
• ASOs In The Neurodegenerative Disease Space
  
• Empowering Enhanced Oligo Delivery To Improve RNA Modulating Therapies In Rare Muscle Diseases
  
• Utilizing Endolysosomal Trafficking To Enhance Effective Oligo Delivery Safely

Next Generation RNA

Venture into emerging applications of RNA 2.0 such circRNA, lncRNAs, RNA editing, delivery tools and RNA as target. Including:

• RNA to deliver RNA’ – Programmable Delivery Systems For Targeted Non-hepatic Delivery 
  
• Next-Generation Lipid Nanoparticle Technology Enabling Extrahepatic Nucleic Acid Delivery
  
• Utilizing Transcriptome-Wide Screening To Identify RNA Targets
  
• Targeting Age-Related Diseases with Controllable Self-Replicating RNAs
  
• Precision tRNA Reprogramming — New Approaches To Correcting Translational Dysfunction In Cancer